Using Patient-Reported Outcomes to Measure Symptoms in Children With Advanced Cancer

Kathleen E Montgomery1, Jennifer L Raybin, Jessica Ward

  • 1Author Affiliations: Department of Nursing, American Family Children's Hospital, Madison, Wisconsin (Dr Montgomery); Center for Cancer and Blood Disorders and Palliative Care, Aurora, Colorado (Ms Raybin); Institute for Nursing and Interprofessional Research (Dr Ward and Dr Murray) and Center for Cancer and Blood Disease (Ms Balian), Children's Hospital Los Angeles, California; Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Ohio (Ms Gilger); and Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison (Dr Li).

Cancer Nursing
|June 20, 2020
PubMed

Insights

Electronic symptom assessment is feasible for children with advanced cancer. This method effectively captures symptom frequency, severity, and distress, especially in the final 12 weeks of life.

Area of Science:

  • Pediatric Oncology
  • Symptom Management
  • Digital Health

Background:

  • Children with advanced cancer often experience persistent symptoms despite quality care.
  • Previous symptom research relied on retrospective data and parent proxies, not prospective self-reports.
  • There's a need for accurate, real-time symptom assessment in this population.

Purpose of the Study:

  • To evaluate the feasibility of electronic data collection for symptom assessment in children with advanced cancer.
  • To measure symptom frequency, severity, and distress using self-report.
  • To understand the symptom experience of pediatric cancer patients.

Main Methods:

  • A multisite prospective cohort study design was employed.
  • Inclusion criteria: 7-18 years old, English-speaking, advanced cancer diagnosis.
  • Symptom data collected electronically every two weeks.

Main Results:

  • High completion rate (91%) for electronic symptom assessments across 46 children.
  • Most frequently reported symptoms: pain, fatigue, nausea, and sleep difficulties.
  • Symptoms like pain and eating difficulties were more frequent in the last 12 weeks of life.

Conclusions:

  • Electronic data collection is a feasible and effective method for assessing symptom constellations in pediatric oncology.
  • Children with advanced cancer experience significant physical and psychological symptoms, particularly near end-of-life.
  • Comprehensive symptom assessment (frequency, severity, distress) can improve patient care and symptom management.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
573
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.5K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
463